Home
Home » companies

Bristol-Myers Squibb

Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery

Common Drug Has The Potential To Slow Aging, Boost Cancer Recovery
Forbes

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?
Seeking Alpha

4 Pharmaceutical Stocks to Buy Now

4 Pharmaceutical Stocks to Buy Now
InvestorPlace

Bristol-Myers earnings could double by end of decade, says Goldman

Bristol-Myers earnings could double by end of decade, says Goldman
Yahoo/Fly on the Wall

3 Big Concerns for the Pharmaceutical Industry

3 Big Concerns for the Pharmaceutical Industry
Motley Fool

BDR Pharma seeks India license for Bristol-Myers drug

BDR Pharma seeks India license for Bristol-Myers drug
Reuters

Why AstraZeneca Will Disappoint In 2013

Why AstraZeneca Will Disappoint In 2013
Seeking Alpha

Does Bristol-Myers' Dividend Have Room to Soar?

Does Bristol-Myers' Dividend Have Room to Soar?
Motley Fool

Longer Lasting Drugs Make For Longer Lasting Profits

Longer Lasting Drugs Make For Longer Lasting Profits
Seeking Alpha

Diabetes Drugs Are Being Evaluated for Pancreatic Risk

Diabetes Drugs Are Being Evaluated for Pancreatic Risk
Bloomberg